FOAMIX PHARMACEUTICALS
FOAMIX PHARMACEUTICALS
Ouverture: -
Variation: -
Volume: -
+ Bas: -
+ Haut: -
Ecart + Bas / + Haut: -
Type: Actions
Ticker: FOMX
ISIN: IL0011334385

URGENT NEWS: Monteverde & Associates PC Announces an Investigation of FOAMIX PHARMACEUTICALS LTD - FOMX

  • 69
URGENT NEWS: Monteverde & Associates PC Announces an Investigation of FOAMIX PHARMACEUTICALS LTD - FOMX

PR Newswire

NEW YORK, Nov. 15, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Foamix Pharmaceuticals, Ltd. ("Foamix" or the "Company") (Nasdaq: FOMX) relating to the sale of the Company to Menlo Therapeutics, Inc. Under the terms of the transaction, Foamix shareholders will have the right to receive 0.5924 shares of Menlo common stock and one contingent stock right for each Foamix common stock owned.

Monteverde & Associates PC Logo

The investigation focuses on whether Foamix and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company's by 1) failing to conduct a fair process and 2) whether and by how much this proposed transaction undervalues the Company.

Click here for more information: https://www.monteverdelaw.com/case/foamix-pharmaceuticals-ltd. It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing.  Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.

If you own common stock in Foamix Pharmaceuticals, Ltd and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected] 
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC.  The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/urgent-news-monteverde--associates-pc-announces-an-investigation-of-foamix-pharmaceuticals-ltd---fomx-300958781.html

SOURCE Monteverde & Associates PC

PR Newswire
PR Newswire

PR Newswire est une agence de presse américaine, située à New York spécialisée dans la publication de communiqués de presse.